-
Canada's Davies 'available' for historic knockout clash
-
Ryu takes one-shot lead over Henderson at Women's PGA Championship
-
Hovland seizes one-shot PGA Travelers lead over Scheffler
-
Jangoo and Chase put West Indies in control against Sri Lanka
-
Mauvaka double inspires Toulouse to fourth-straight Top 14 in storm-impacted final
-
World Cup star Gakpo requests privacy after death of unborn son
-
Solidarity, sadness among Venezuelans made destitute by quake
-
Aid planes landing at partially reopened Venezuela airport after quakes
-
Iran says US violated peace deal as both sides attack
-
Spain's Williams hits out at Uruguay over World Cup injury
-
'We need help': Venezuelans furious at slow official response to quakes
-
World's largest particle smasher halts for upgrade to boost hunt for dark matter
-
Venus Williams relishes 'very special' Wimbledon reunion with sister Serena
-
Ex-Olympic medallist Canderloro elected French Ice Sports chief
-
Ravindra leads New Zealand rally in England finale after Archer's double strike
-
Prince Harry and family to stay at royal residences on UK visit
-
Wimbledon 'towel thief' Swiatek back on the trophy hunt
-
'Why not?': Cape Verde eye seismic World Cup shock against Argentina
-
Venezuela earthquake deaths near 1,000, with millions more in need
-
Russell snatches controversial pole in Austria after Verstappen crash
-
French Open champs head to Wimbledon wrestling with new-found status
-
Davidovich Fokina wins in Mallorca for first ATP title
-
Budapest Pride marchers push for equality after reversed ban
-
Sabalenka urges Grand Slams to 'get it done' in prize money boycott row
-
Russell snatches pole, Antonelli fourth for Austria GP grid
-
Russell snatches pole as Verstappen, Antonelli fourth for Austria GP grid
-
Broos smiles and snarls before South Africa's historic World Cup match
-
Smith and supersub Foulkes strike for New Zealand in England finale
-
Newborn baby rescued from rubble of Venezuela quake
-
Supersub Foulkes strike for New Zealand in England finale
-
Raducanu halts practice session to put Wimbledon bid in doubt
-
Wolff says Russell will be at Mercedes next season
-
Keys beats Maria to clinch third Eastbourne title
-
Djokovic inspired by Serena as he targets history at Wimbledon
-
Thousands ride through Rome as Vespa celebrates 80 years
-
Stokes falls cheaply as England collapse in New Zealand decider
-
Sinner ready for Wimbledon defence despite lack of time on grass
-
Russell bounces back to beat Antonelli in final practice
-
Records tumble as European heatwave moves east
-
Iran says US violated peace deal as both sides trade fire
-
England, Portugal eye top spots as World Cup group stages wrap up
-
Injured Australian pair Leckie, Italiano out of World Cup
-
US, Iran trade strikes putting new strain on Middle East truce
-
Farmers fear drought as Italy's longest river runs dry
-
Thousands expected as Vespa celebrates 80 years in Rome
-
Budapest Pride to push for equality after reversed ban
-
Pino, Williams injuries mar Spain's World Cup progress
-
World Cup fans get taste of American life -- at the mall
-
'Struggle continues' in Bolivia's Morales heartland
-
World Cup turns New York's Times Square into global fan hub
Exousia Pro Issues Update on Name Change
ORLANDO, FLORIDA / ACCESS Newswire / April 3, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases, is pleased to announce that the Company has received comments from FINRA regarding the name change.
FINRA has requested specific Board minutes and the stamped Articles of Amendment from the State of Florida showing the name change from Marijuana, Inc. to Exousia Pro, Inc.
We submitted the Articles of Amendment to the filer yesterday, and they will be forwarded to the State this morning. To facilitate the Name change, the name of our subsidiary had to be changed from Exousia Pro, Inc. to Exousia AI, Inc., to release the name for the parent company.
"This is a positive indicator that the process is moving along, as evidenced by hearing from FINRA within the first 30 days of the filing," said Matthew Dwyer, President of Exousia Pro, Inc.
About us
Exousia Pro is a clinical-stage biotechnology company developing new ways to exploit the therapeutic potential of exosomes, initially focused on oncology. The company's patented manufacturing process utilizes plant-based materials to create exosomes used in a number of commercial applications from dermatology to dentistry. The company's proprietary loading technology can infuse a range of molecules from drugs to DNA.
For more information, please visit: www.exousiapro.com
SAFE HARBOR
Forward-looking statements in this release are made under the "safe harbor" provision of the Private Securities Litigation Reform Act of 1995. Ludwig Enterprises Inc.'s forward-looking statements do not guarantee future performance. This news release includes forward-looking statements concerning the future level of business for the parties. These statements are necessarily subject to risk and uncertainty. Actual results could differ materially from those projected in these forward-looking statements due to certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Ludwig Enterprises, Inc., and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, appropriately price, retain, and complete projects and changes in products and competition.
CONTACT:
Marijuana, Inc.
www.Exousiapro.com
Twitter: @Exousia_Pro
Investor Relations
[email protected]
SOURCE: Marijuana Inc.
View the original press release on ACCESS Newswire
P.A.Mendoza--AT